Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

of

Prof Adam Finn @ MRF's Meningitis and Septicaemia 2019 Slide 1 Prof Adam Finn @ MRF's Meningitis and Septicaemia 2019 Slide 2 Prof Adam Finn @ MRF's Meningitis and Septicaemia 2019 Slide 3 Prof Adam Finn @ MRF's Meningitis and Septicaemia 2019 Slide 4 Prof Adam Finn @ MRF's Meningitis and Septicaemia 2019 Slide 5 Prof Adam Finn @ MRF's Meningitis and Septicaemia 2019 Slide 6 Prof Adam Finn @ MRF's Meningitis and Septicaemia 2019 Slide 7 Prof Adam Finn @ MRF's Meningitis and Septicaemia 2019 Slide 8 Prof Adam Finn @ MRF's Meningitis and Septicaemia 2019 Slide 9 Prof Adam Finn @ MRF's Meningitis and Septicaemia 2019 Slide 10 Prof Adam Finn @ MRF's Meningitis and Septicaemia 2019 Slide 11 Prof Adam Finn @ MRF's Meningitis and Septicaemia 2019 Slide 12 Prof Adam Finn @ MRF's Meningitis and Septicaemia 2019 Slide 13 Prof Adam Finn @ MRF's Meningitis and Septicaemia 2019 Slide 14 Prof Adam Finn @ MRF's Meningitis and Septicaemia 2019 Slide 15 Prof Adam Finn @ MRF's Meningitis and Septicaemia 2019 Slide 16 Prof Adam Finn @ MRF's Meningitis and Septicaemia 2019 Slide 17
Upcoming SlideShare
What to Upload to SlideShare
Next
Download to read offline and view in fullscreen.

0 Likes

Share

Download to read offline

Prof Adam Finn @ MRF's Meningitis and Septicaemia 2019

Download to read offline

Debate - pneumococcal vaccination - is a second year of life booster needed for herd protection?

Related Books

Free with a 30 day trial from Scribd

See all

Related Audiobooks

Free with a 30 day trial from Scribd

See all
  • Be the first to like this

Prof Adam Finn @ MRF's Meningitis and Septicaemia 2019

  1. 1. PCV in developing countries Give 2+1 Adam Finn @adamhfinn Bristol Childrens Vaccine Centre MRF 5th Nov 2019, London
  2. 2. Is this your ideal perspective?
  3. 3. ..or do you prefer to take the broader view?
  4. 4. PCVs have important indirect effects
  5. 5. This is not new... Lancet Infectious Diseases 2001
  6. 6. Salivary antibody responses Choo et al. JID 2000 182
  7. 7. Functional antibody after priming wanes..
  8. 8. Functional antibody after boosting persists..
  9. 9. More antibody.. Madhi & Nunes Hum Vaccin Immunother. 2016 Feb; 12(2): 314–325
  10. 10. VT carriage - Kenya Hammitt et al Lancet Glob Health. 2014 Jul;2(7):e397-405
  11. 11. ..and, of course, it’s not just about indirect protection..
  12. 12. From 12 months post-dose 3, the odds of VT IPD by 24–36 months increased significantly for PCV7 (5.6, 95% CI, 1.2– 25.4) and PCV13 (5.9, 95% CI, 1.0–35.2).
  13. 13. So: • 3+0 provides direct protection for a limited period – as shown in 2 RCTs. • For people with blinkers it’s a dead cert to do that – and only that • 2+1 provides both sustained direct and indirect protection across the population • For people with a broader perspective it’s the obvious choice • More evidence on 2+1 is coming soon

Debate - pneumococcal vaccination - is a second year of life booster needed for herd protection?

Views

Total views

4,068

On Slideshare

0

From embeds

0

Number of embeds

3,728

Actions

Downloads

0

Shares

0

Comments

0

Likes

0

×